We use cookies for analytics and ads to improve your experience. You can accept or decline. See our Privacy Policy.
Capital appreciation through disciplined mid and small cap investing.
Molecule Ventures is a SEBI registered Portfolio Management Services (PMS) firm focused on achieving capital appreciation through medium to long-term investments in quality companies with strong growth prospects, primarily in the mid and small cap segment. The firm emphasizes strong growth opportunities, quality management and strict risk mitigation by avoiding valuation and balance sheet risks.
Non-Linearity: Markets move between under-valuation and over-valuation. Long-term earnings drive prices but the journey is never linear. Longevity: Survival through risk management is key to long-term success. Compounding: Focus on long-term compounding in fundamentally strong businesses run by capable management. Portfolio Allocation: Core Basket (Secular + Medium Term): 75-80% Opportunistic / Market Driven: 20-25%
NIRAV PARIKH
Co-Founder / Principal Officer
Nearly two decades of investing experience in small and mid-size companies. Previously with Reliance Equities and Alchemy Capital. MBA from NMIMS, CFA (US), FRM.
MITIN JAIN
Co-Founder
Close to two decades of experience across Private Equity, Investment Banking and Listed Investing. Founder & MD of India SME Investments (AIF Cat 2).
SALONI HEMNANI
Analyst
AASHAV PATEL
Analyst
RITESH CHOUDHARY
Analyst
KRISHA KANSARA
Analyst
PUJAN SHAH
Analyst
PANKAJ PARAB
Associate
DHVITI SHAH
Associate
YUG JHAVERI
Associate
No insights published yet.
Investments in securities markets are subject to market risks. Read all the related documents carefully before investing. Past performance is not indicative of future returns.
DHRUV NAWAB
Quantitative Analyst
DHWIJESH VANKAWALA
Quantitative Analyst
ANCHAL GOENKA
Operations Manager
TARUN AMIPARA
Operations Associate